Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.
Aikou OkamotoAsumi OkumuraToshiaki NakamuraSatoshi YanagidaJunzo HamanishiKenichi HaranoKosei HasegawaTakeshi HirasawaKensuke HoriShinichi KomiyamaMotoki MatsuuraHidekatsu NakaiHiroko NakamuraJun SakataTsutomu TabataKazuhiro TakeharaMunetaka TakekumaYoshihito YokoyamaYoichi KaseShuuji SuminoJunpei SoedaAjit SuriDaisuke AokiToru SugiyamaPublished in: Journal of gynecologic oncology (2020)
ClinicalTrials.gov Identifier: NCT03759600.
Keyphrases